DPX-SurMAGE/CPA

N/A

Report date: 2024/04/09 14:45:25

Base Information

Drug NameDPX-SurMAGE/CPA
Drug Alias NameSURVIVIN+MAGE A9 targeted therapy (BioVaxys Technology)DPX-SurMAGE/CPADPX-SurMAGEDPX™-survivin/MAGE A9DPX™ SurMAGE
ClassificationVaccines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIMV Inc
China Registration ClassN/A

Develop Information

Active CompaniesBioVaxys Technology Corp
Inactive CompaniesN/A
Active IndicationsUrinary Bladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A